You have 9 free searches left this month | for more free features.

Adenosine 2A Receptor Antagonist

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

Not yet recruiting
  • Spinal Cord Injuries
  • Myelopathy
  • Cambridge, Massachusetts
    Spaulding Rehabilitation Hospital
Jun 24, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

ALS Trial in Gainesville (Consume 20mg of istradefylline, Low Oxygen therapy, Placebo counterpart to the istradefylline drug)

Recruiting
  • ALS
  • Consume 20mg of istradefylline
  • +3 more
  • Gainesville, Florida
    Clinical and Translational Research Building
Jul 5, 2022

Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)

Recruiting
  • Rectal Cancer
  • Etrumadenant (AB928)
  • +3 more
  • New York, New York
  • +2 more
Apr 10, 2022

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 9, 2022

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Receptor Blockade Trial in Fort Collins (Adenosine Triphosphate, Acetylcholine, Sodium Nitroprusside)

Completed
  • Receptor Blockade
  • Adenosine Triphosphate
  • +8 more
  • Fort Collins, Colorado
    Human Performance and Clinical Research Laboratory
Jul 26, 2021

Cough Trial (device, diagnostic test, procedure)

Not yet recruiting
  • Cough
  • Adenosine triphosphate (ATP) solution inhalation from nebuliser
  • +7 more
  • (no location specified)
Jan 26, 2023

Chronic Coronary Syndromes Trial in Marseille (blood samples)

Recruiting
  • Chronic Coronary Syndromes
  • blood samples
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Dec 20, 2021

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Stress Disorders, Posttraumatic
  • San Francisco, California
  • +1 more
Nov 10, 2022

Hypercholesterolemia Trial in Marseille (Blood sample)

Recruiting
  • Hypercholesterolemia
  • Blood sample
  • Marseille, France
    Service Endocrinologie
Nov 8, 2021

s to Learn More About Treatment With Steroidal Mineralocorticoid

Active, not recruiting
  • Chronic Kidney Disease
  • +2 more
  • sMRA therapies
  • Whippany, New Jersey
    Many Locations
Jan 30, 2023

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

Not yet recruiting
  • Neuroendocrine Neoplasia's (NENs)
  • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
  • Basel, Switzerland
    Division of Nuclear Medicine, University Hospital Basel
Apr 27, 2022

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

Not yet recruiting
  • Primary Aldosteronism
  • Hypertension
  • (no location specified)
Apr 3, 2023

PTSD Trial in San Francisco (CORT108297, Placebo)

Not yet recruiting
  • PTSD
  • San Francisco, California
    San Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022

Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • San Antonio, Texas
    Texas Diabetes Institute
Dec 22, 2021